C-peptide and captopril are equally effective in lowering glomerular hyperfiltration in diabetic rats

Nephrology Dialysis Transplantation

Volumn 19, Issue 6, 2004, Pages 1385-1391

  Samnegård, Björn ^a,c   Jacobson, Stefan H ^b   Johansson, Bo Lennart ^b   Ekberg, Karin ^b   Isaksson, Britta ^c   Wahren, John ^b   Sjöquist, Mats ^c  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

C peptide; Captopril; Diabetic nephropathy; Glomerular hyperfiltration; Renal blood flow

Indexed keywords

C PEPTIDE; CAPTOPRIL; PLACEBO; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INFUSION; DRUG URINE LEVEL; GLOMERULUS FILTRATION RATE; INULIN CLEARANCE; KIDNEY BLOOD FLOW; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; STREPTOZOCIN DIABETES; ULTRASOUND;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; C-PEPTIDE; CAPTOPRIL; DIABETES MELLITUS, EXPERIMENTAL; GLOMERULAR FILTRATION RATE; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

EID: 2942707879     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh163     Document Type: Article

References (19)

1. Ido Y, Vindigni A, Chang K et al. Prevention of vascular and neural dysfunction in diabetic rats by C-peptide. Science 1997; 277: 563-566
2. Sima AA, Zhang W, Sugimoto K et al. C-peptide prevents and improves chronic type I diabetic polyneuropathy in the BB/Wor rat. Diabetologia 2001; 44: 889-897
3. Johansson BL, Borg K, Fernqvist-Forbes E, Odergren T, Remahl S, Wahren J. C-peptide improves autonomic nerve function in IDDM patients. Diabetologia 1996; 39: 687-695
4. Ekberg K, Brismar T, Johansson BL, Jonsson B, Lindstrom P, Wahren J. Amelioration of sensory nerve dysfunction by C-peptide in patients with type 1 diabetes. Diabetes 2003; 52: 536-541
5. Johansson BL, Sjoberg S, Wahren J. The influence of human C-peptide on renal function and glucose utilization in type 1 (insulin-dependent) diabetic patients. Diabetologia 1992; 35: 121-128
6. Johansson BL, Kernell A, Sjoberg S, Wahren J. Influence of combined C-peptide and insulin administration on renal function and metabolic control in diabetes type 1. J Clin Endocrinol Metab 1993; 77: 976-981
7. Johansson BL, Borg K, Fernqvist- Forbes E, Kernell A, Odergren T, Wahren J. Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with type 1 diabetes mellitus. Diabet Med 2000; 17: 181-189
8. Samnegard B, Jacobson SH, Jaremko G, Johansson BL, Sjoquist M. Effects of C-peptide on glomerular and renal size and renal function in diabetic rats. Kidney Int 2001; 60: 1258-1265
9. Sjoquist M, Huang W, Johansson BL. Effects of C-peptide on renal function at the early stage of experimental diabetes. Kidney Int 1998; 54: 758-764
10. Rigler R, Pramanik A, Jonasson P et al. Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci USA 1999; 96: 13 318-13 323
11. Johansson J, Ekberg K, Shafqat J et al. Molecular effects of proinsulin C-peptide. Biochem Biophys Res Commun 2002; 295: 1035-1040
12. Viberti G, Mogensen CE, Groop LC, Pauls JF. Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group. JAMA 1994; 271: 275-279
13. The EUCLID study group. Randomised placebo-controlled trial of lisinopril in normotensive patients with insulin-dependent diabetes and normoalbuminuria or microalbuminuria. The EUCLID Study Group. Lancet 1997; 349: 1787-1792
14. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. N Engl J Med 1993; 329: 1456-1462
15. Mogensen CE, Christensen CK. Predicting diabetic nephropathy in insulin-dependent patients. N Engl J Med 1984; 311: 89-93
16. Mogensen CE. Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy. Scand J Clin Lab Invest 1986; 46: 201-206
17. Rudberg S, Persson B, Dahlquist G. Increased glomerular filtration rate as a predictor of diabetic nephropathy - an 8-year prospective study. Kidney Int 1992; 41: 822-828
18. Giudicelli JF, Richer C, Richard C, Thuillez C. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans. Am J Hypertens 1991; 4: 258S-262S
19. Huang DY, Richter K, Breidenbach A, Vallon V. Human C-peptide acutely lowers glomerular hyperfiltration and proteinuria in diabetic rats: a dose-response study. Naunyn Schmiedebergs Arch Pharmacol 2002; 365: 67-73